Financial Summary (All financials)
In millions, except per share items | Mar-31-18 | Mar-31-17 | Mar-31-16 | Mar-31-15 | Mar-31-14 | Mar-31-13 | Mar-31-12 | Mar-31-11 |
Revenues | 86.9 | 77.9 | 100.5 | 42.6 | 35.6 | 30.5 | 27.5 | 17.8 |
Revenue growth | 11.5% | -22.5% | 135.8% | 19.8% | 16.7% | 10.7% | 55.0% | -19.1% |
Cost of goods sold | 61.0 | 56.0 | 69.2 | 28.3 | 22.9 | 20.1 | 19.1 | 12.3 |
Gross profit | 25.9 | 22.0 | 31.3 | 14.3 | 12.7 | 10.4 | 8.4 | 5.4 |
Gross margin | 29.8% | 28.2% | 31.2% | 33.6% | 35.7% | 34.1% | 30.5% | 30.5% |
Sales and marketing | 14.4 | 12.4 | 15.1 | 6.4 | 6.1 | 4.2 | 3.8 | 3.0 |
Research and development | 3.4 | 4.5 | 5.8 | 3.5 | 4.9 | 2.2 | 1.5 | 2.1 |
General and administrative | 7.4 | 7.2 | 9.4 | 4.1 | 4.2 | 3.6 | 3.3 | 3.0 |
EBIT | 0.7 | -2.1 | 0.1 | 0.3 | -2.4 | 0.4 | -0.2 | -2.6 |
EBIT margin | 0.8% | -2.6% | 0.1% | 0.8% | -6.8% | 1.5% | -0.9% | -14.7% |
Pre-tax income | 0.3 | -2.4 | -0.4 | 0.3 | -1.8 | 0.3 | -0.5 | -6.4 |
Income taxes | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 2.3% | | 1.6% | 13.5% | 0.7% | 10.3% | 0.0% | 0.0% |
Net income | 0.3 | -2.6 | -0.4 | 0.2 | -1.8 | -2.0 | -5.1 | -9.2 |
Net margin | 0.3% | -3.3% | -0.4% | 0.6% | -4.9% | -6.5% | -18.6% | -52.1% |
|
Diluted EPS | $0.03 | ($0.23) | ($0.03) | $0.03 | ($0.21) | ($0.51) | ($10.00) | ($0.06) |
Shares outstanding (diluted) | 11.0 | 10.9 | 10.8 | 8.8 | 8.4 | 3.9 | 0.5 | 152.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|